Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bone Turnover Markers in Patients With Ossification of the Posterior Longitudinal Ligament in the Thoracic Spine. | Spine (Phila Pa 1976) | 2024 | 37339262 | PubTator, text mining | PubMed |
| Case report: Refractory Evans syndrome in two patients with spondyloenchondrodysplasia with immune dysregulation treated successfully with JAK1/JAK2 inhibition. | Front Immunol | 2023 | 38347954 | PubTator, text mining | PubMed |
| Lessons learned from rapid exome sequencing for 575 critically ill patients across the broad spectrum of rare disease. | Front Genet | 2023 | 38259611 | PubTator, text mining | PubMed |
| Factors Associated With Nonunion After Cervical Fusion Surgery. | Cureus | 2023 | 38249174 | PubTator, text mining | PubMed |
| Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis prediction. | Front Immunol | 2023 | 38169731 | PubTator, text mining | PubMed |
| Single-cell RNA landscape of osteoimmune microenvironment in osteoporotic vertebral compression fracture and Kümmell's disease. | Front Cell Dev Biol | 2023 | 38161331 | PubTator, text mining | PubMed |
| A Pilot Study About the Role of PANoptosis-Based Genes in Atherosclerosis Development. | J Inflamm Res | 2023 | 38149113 | PubTator, text mining | PubMed |
| Changes in Serum Concentrations of Bone Turnover Markers in Healthy Pregnant Women. | Int J Clin Pract | 2023 | 38145116 | PubTator, text mining | PubMed |
| Pathophysiology and Therapeutic Management of Bone Loss in Patients with Critical Illness. | Pharmaceuticals (Basel) | 2023 | 38139844 | PubTator, text mining | PubMed |
| Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk. | Int J Mol Sci | 2023 | 38139166 | PubTator, text mining | PubMed |
| Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases. | Int J Mol Sci | 2023 | 38138968 | PubTator, text mining | PubMed |
| A Retrospective Histological Study on Palatal and Gingival Mucosa Changes during a Rapid Palatal Expansion Procedure. | Biomedicines | 2023 | 38137467 | PubTator, text mining | PubMed |
| CSF2RB mutation-related hereditary pulmonary alveolar proteinosis: the "long and winding road" into adulthood. | ERJ Open Res | 2023 | 38111540 | PubTator, text mining | PubMed |
| Osteoporosis: Investigations and Monitoring. | Indian J Orthop | 2023 | 38107808 | PubTator, text mining | PubMed |
| Bilateral Lumbar Pedicle Fracture in a Patient Receiving Long-Term Bisphosphonate Therapy: A Case Report. | Spine Surg Relat Res | 2023 | 38084218 | PubTator, text mining | PubMed |
| Association of ACP5 with the tumor immune microenvironment and its role in cell proliferation and metastasis in pancreatic cancer. | Am J Transl Res | 2023 | 38074824 | PubTator, text mining | PubMed |
| Circulating sRANKL, Periostin, and Osteopontin as Biomarkers for the Assessment of Activated Osteoclastogenesis in Myeloma Related Bone Disease. | Cancers (Basel) | 2023 | 38067265 | PubTator, text mining | PubMed |
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 | 38067234 | PubTator, text mining | PubMed |
| The Research Progress in Transforming Growth Factor-β2. | Cells | 2023 | 38067167 | PubTator, text mining | PubMed |
| Urinary single-cell sequence analysis of the urinary macrophage in different outcomes of membranous nephropathy. | Clin Kidney J | 2023 | 38046013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=15